About Abound Bio
Abound Bio is a Healthcare company based in Pittsburgh (United States) founded in 2019, and was acquired by Galapagos in June 2022. Provider of discover, development, and manufacturing services for cancer and infectious disease. Abound Bio offers products and services including Antibody Therapeutics, Cell Therapy, and Small Molecules. Its focus areas include Biopharma Outsourcing, Diversified and Biologics. Its legal entity is Galapagos NV. Its competitors include Catalent, Surrozen and Curia; 1 of its 3 listed competitors has raised funding.
Company details
Abound Bio was founded in 2019 and is based in Pittsburgh, United States. Operations are centered in the biotechnology sector, where discovery, development, and manufacturing services are delivered for cancer and infectious disease applications. Focus is maintained on supporting therapeutic advancements through these core functions, with activities conducted from the companys location in the United States. The domain aboundbio.com is utilized for online presence.
- Headquarters Pittsburgh, United States
- Stage Acquired
- SectorsHealthcare
- Website aboundbio.com
- Social LinkedIn
- Acquired by Galapagos (Jun 2022)
- Legal Name Galapagos Nv
Products & Services of Abound Bio
Abound Bio offers a comprehensive portfolio of products and services, including Antibody Therapeutics, Cell Therapy, and Small Molecules.
Develops treatments for cancer using antibodies
Advances cell-based solutions for infectious diseases
Creates compounds for disease management
Investors in Abound Bio
Abound Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include GLPG.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Small molecule drugs for immunology and oncology are developed. | 1999 | glpg.com | Mechelen, Belgium |
Investor details for Abound Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Abound Bio
18 people are tracked at Abound Bio (5 in leadership, 4 in board & advisors, 9 in team).
| Name | Role | Group |
|---|---|---|
John Mellors | President & CEO | Leadership |
Dimiter Dimitrov | EVP & Chief Scientific Officer | Leadership |
Alex Conard | Laboratory Management Director, Scientist 1 | Leadership |
Gabriella Merritt | Director of Operations | Leadership |
Cynthia Adams | Director of Pre-Clinical Development, Scientist 1 | Leadership |
Joel B. Nelson | Chairman | Board & advisors |
Prasad S Adusumilli | Scientific Advisor | Board & advisors |
Ronald J. Buckanovich | Scientific Advisor | Board & advisors |
Rimas Orentas | Scientific Advisor | Board & advisors |
Edward Goncz | Scientist 1 | Team |
Zehua Sun | Principal Scientist | Team |
Abigail Berrios | Laboratory Technician | Team |
Taylor Napierkowski | Laboratory Technician | Team |
Chiquita Hanindya | Associate Scientist | Team |
Rebecca Wright | Laboratory Technician | Team |
Ping Sun | Senior Scientist | Team |
Du-San Baek | Principal Scientist | Team |
Christy Roush | Laboratory Technician | Team |
Complete people profiles for Abound Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Abound Bio
2 dated milestones of Abound Bio across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Abound Bio is founded.
- Exit Acquired by Galapagos.
Competitors of Abound Bio
Abound Bio has 3 listed competitors in our database, 1 of them funded. They include Catalent, Surrozen and Curia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| catalent.com | 2007 | Somerset, United States | 9,390 | CDMO offering drug and biologics development services | ||
| surrozen.com | 2016 | San Francisco, United States | $133M | 80 | Selective Wnt agonists are developed for human tissue regeneration. | |
| curiaglobal.com | 1991 | Albany, United States | 1,918 | Drug research, development, testing, and consulting services are provided. |
Detailed competitors of Abound Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Abound Bio (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Abound Bio
Complete news archive for Abound Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abound Bio
Abound Bio was founded in 2019.
Abound Bio is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Abound Bio was founded in 2019 and is based in Pittsburgh, United States. Operations are centered in the biotechnology sector, where discovery, development, and manufacturing services are delivered for cancer and infectious disease applications. Focus is maintained on supporting therapeutic advancements through these core functions, with activities conducted from the companys location in the United States. The domain aboundbio.com is utilized for online presence.
Abound Bio offers Antibody Therapeutics, Cell Therapy, and Small Molecules.
Abound Bio has 1 investor. Key investors include GLPG.
Abound Bio operates through Galapagos Nv.
Yes. Abound Bio was acquired by Galapagos in June 2022.